← SynDRA
SETIPIPRANT
SynDRA canonical compound SYN0037331 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PTGDR2 |
|---|
| Mechanism of action | prostaglandin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PTGDR2 ANTAGONIST
- G protein-coupled receptor 44 antagonist
- prostaglandin inhibitor
- PTGDR ANTAGONIST
Cross-references
Synonyms
- ACT-129968
- KYTH-105
- ACT 129968
- BHF20LA2GM
- setipiprantum
- RefChem:931658
- DTXCID80158230
- MFCD23136043
- Setipiprant(ACT129968)
- Setipiprant [INN]
- UNII-BHF20LA2GM
- Setipiprant [USAN:INN]
- ACT129968
- Setipiprant (USAN/INN)
- SETIPIPRANT [USAN]
- SETIPIPRANT [WHO-DD]
- Setipiprant(ACT-129968)
- orb1304123
- orb3141178
- SCHEMBL3089969
- Setipiprant (ACT-129968)
- SCHEMBL29355657
- SCHEMBL29358337
- C24H19FN2O3
- GTPL10180
- CHEBI:177430
- GLXC-10792
- EX-A1767
- RJB46033
- BDBM50434990
- AKOS016340337
- BH-0015
- CS-4940
- SB18924
- compound 28 [PMID: 23721423]
- AC-31955
- DA-57813
- HY-16635
- Setipiprant(ACT-129968, KYTH-105)
Look up SETIPIPRANT in the interactive SynDRA portal →